Actively Recruiting
Evaluating Efferon LPS Hemoadsorption to Reduce Multiple Organ Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass
Led by Efferon JSC · Updated on 2026-08-26
60
Participants Needed
3
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of the Efferon LPS device, a hemoadsorption device, in patients undergoing cardiac surgery with cardiopulmonary bypass. The trial aims to assess whether using hemoadsorption during and soon after surgery can reduce the incidence and severity of multiple organ dysfunction syndrome MODS in the postoperative period. This research focuses on patients at risk due to ischemia-reperfusion injury and complications such as acute kidney injury AKI, which are common after cardiac surgery. Participants in the treatment group will receive two hemoadsorption sessions with the Efferon LPS device one during cardiopulmonary bypass while the heart-lung machine is used, with the session length matching the bypass duration, and a second session within 24 hours after surgery lasting at least six hours. The control group will receive standard cardiac surgery care with cardiopulmonary bypass but without hemoadsorption. The study compares these two approaches to evaluate the devices impact. During the study, participants will be monitored for organ function using the SOFA score from days 1 to 7 after surgery. Additional outcomes include time without vasopressor support, duration of renal replacement therapy and mechanical ventilation, length of ICU stay, incidence of postoperative complications, and mortality within 28 days. Safety and efficacy are assessed through these measures, with follow-up extending to 28 days after surgery. The total study duration spans from 2026 to 2028.
CONDITIONS
Brief Title
Efferon LPS Hemoadsorption in Cardiac Surgery Patients
Research Team
A
Alexandr Shelehov-Kravchenko, PhD, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here